| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6176453 | European Urology | 2015 | 4 Pages |
Abstract
Discussion of possible overtreatment has led to dramatic changes in indication for radical prostatectomy (RP). We analyzed a large European patient cohort and found that RP is rarely done in early cancers but is used more for aggressive tumors. Those who underwent RP had long life expectancy and benefit from surgery. With this change in application, overtreatment with RP is unlikely.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Hartwig Huland, Markus Graefen,